Clinical trial

An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)

NCT03055338

Study summary

ClinicalTrials.gov

An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Elpipodect Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Risperidone Normalized identity: risperidone View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo matching MK-8189 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo matching risperidone Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-03-08

PhasePHASE2

Conditions

Schizophrenia, Acute Episodeunresolved

Interventions

ElpipodectDRUG

RisperidoneDRUG · verified · RxNorm: risperidone

Placebo matching MK-8189DRUG

Placebo matching risperidoneDRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Mapped research locations

St LouisMissouri, United States2 AtlantaGeorgia, United States2 New YorkNew York, United States1 San DiegoCalifornia, United States1 OrlandoFlorida, United States1 Las VegasNevada, United States1 Little RockArkansas, United States1 OrangeCalifornia, United States1 DaytonOhio, United States1 TorranceCalifornia, United States1 HollywoodFlorida, United States1 GlendaleCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03055338 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.